Roxan F.C.P. Helderman

498 total citations
16 papers, 349 citations indexed

About

Roxan F.C.P. Helderman is a scholar working on Surgery, Reproductive Medicine and Hepatology. According to data from OpenAlex, Roxan F.C.P. Helderman has authored 16 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 4 papers in Reproductive Medicine and 4 papers in Hepatology. Recurrent topics in Roxan F.C.P. Helderman's work include Intraperitoneal and Appendiceal Malignancies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Ultrasound and Hyperthermia Applications (4 papers). Roxan F.C.P. Helderman is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Ultrasound and Hyperthermia Applications (4 papers). Roxan F.C.P. Helderman collaborates with scholars based in Netherlands, Germany and United Kingdom. Roxan F.C.P. Helderman's co-authors include Johannes Crezee, H. Petra Kok, Arlene L. Oei, Nicolaas A.P. Franken, Pieter J. Tanis, Arwin Groenewoud, Gabi W. van Pelt, B. Ewa Snaar‐Jagalska, Henri H. Versteeg and Cornelis F.M. Sier and has published in prestigious journals such as Oncogene, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Roxan F.C.P. Helderman

16 papers receiving 349 citations

Peers

Roxan F.C.P. Helderman

SURGE

ONCOL

Steven J. de Jongh Netherlands

Sophie Vankerckhove Belgium

Dragan Opačić Germany

Atsushi Iida Japan

Shota Hasuda Japan

Shannon F. Rosati United States

Mengxiong Li China

Tomohiro Kanayama Japan

Donatella Tirindelli Danesi Italy

Joanna Jońska‐Gmyrek Poland

Steven J. de Jongh Netherlands

Roxan F.C.P. Helderman

124 ×0.8

SURGE

94 ×1.0

ONCOL

40 ×0.5

163 ×2.4

16 ×0.3

Citations per year, relative to Roxan F.C.P. Helderman Roxan F.C.P. Helderman (= 1×) peers Steven J. de Jongh

Countries citing papers authored by Roxan F.C.P. Helderman

Since Specialization

Citations

This map shows the geographic impact of Roxan F.C.P. Helderman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxan F.C.P. Helderman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxan F.C.P. Helderman more than expected).

Fields of papers citing papers by Roxan F.C.P. Helderman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxan F.C.P. Helderman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxan F.C.P. Helderman. The network helps show where Roxan F.C.P. Helderman may publish in the future.

Co-authorship network of co-authors of Roxan F.C.P. Helderman

This figure shows the co-authorship network connecting the top 25 collaborators of Roxan F.C.P. Helderman. A scholar is included among the top collaborators of Roxan F.C.P. Helderman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxan F.C.P. Helderman. Roxan F.C.P. Helderman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zhang, Le, Prashanthi Ramesh, Roxan F.C.P. Helderman, et al.. (2025). GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells. Oncogenesis. 14(1). 25–25. 1 indexed citations

Helderman, Roxan F.C.P., Kate Cameron, Sander R. van Hooff, et al.. (2025). CDX2 downregulation regulates intrinsic WNT pathway activation, dictating metastasis in APC and CTNNB1 wildtype colorectal cancer. Oncogene. 44(25). 2091–2102. 1 indexed citations

Kok, H. Petra, Roxan F.C.P. Helderman, Nicolaas A.P. Franken, et al.. (2023). Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom. Frontiers in Oncology. 13. 1102242–1102242. 5 indexed citations

Helderman, Roxan F.C.P., Hans M. Rodermond, Wouter Marchal, et al.. (2023). Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin. Frontiers in Oncology. 13. 1122755–1122755. 7 indexed citations

Kok, H. Petra, Roxan F.C.P. Helderman, Nicolaas A.P. Franken, et al.. (2023). Application of HIPEC simulations for optimizing treatment delivery strategies. International Journal of Hyperthermia. 40(1). 2218627–2218627. 5 indexed citations

Helderman, Roxan F.C.P., Hans M. Rodermond, Nicolaas A.P. Franken, et al.. (2022). Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial. Biomedicines. 10(7). 1610–1610. 2 indexed citations

Helderman, Roxan F.C.P., Hans M. Rodermond, Arlene L. Oei, et al.. (2022). A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer. Scientific Reports. 12(1). 7017–7017. 3 indexed citations

Helderman, Roxan F.C.P., Nicolaas A.P. Franken, Arlene L. Oei, et al.. (2021). Simulating drug penetration during hyperthermic intraperitoneal chemotherapy. Drug Delivery. 28(1). 145–161. 21 indexed citations

Helderman, Roxan F.C.P., Hans M. Rodermond, Pieter J. Tanis, et al.. (2021). Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model. International Journal of Hyperthermia. 38(1). 38–54. 11 indexed citations

10.

Helderman, Roxan F.C.P., Pieter J. Tanis, Jurriaan B. Tuynman, et al.. (2021). Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges. Cancers. 13(14). 3430–3430. 16 indexed citations

11.

Kok, H. Petra, Marcus Beck, Roxan F.C.P. Helderman, et al.. (2020). Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems. International Journal of Hyperthermia. 37(1). 76–88. 16 indexed citations

12.

Helderman, Roxan F.C.P., et al.. (2020). Experimental validation of a thermophysical fluid model for use in a hyperthermia treatment planning system. International Journal of Heat and Mass Transfer. 152. 119495–119495. 6 indexed citations

13.

Helderman, Roxan F.C.P., Jan Verhoeff, Hans M. Rodermond, et al.. (2020). The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines. Cells. 9(8). 1775–1775. 49 indexed citations

14.

Helderman, Roxan F.C.P., Jan Sijbrands, Hans M. Rodermond, et al.. (2020). A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats. Cancers. 12(12). 3516–3516. 10 indexed citations

15.

Helderman, Roxan F.C.P., H. Petra Kok, Arlene L. Oei, et al.. (2019). Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review. Cancers. 11(1). 78–78. 64 indexed citations

16.

Paauwe, Madelon, Mark J.A. Schoonderwoerd, Roxan F.C.P. Helderman, et al.. (2018). Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis. Clinical Cancer Research. 24(24). 6331–6344. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact